Balance Sheets (Unaudited) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Assets
Cash and cash equivalents	$ 3,760	$ 6,539
Prepaid expense and other current assets	22,352	61,953
Total current assets	26,112	68,492
Patents, net	88,964	93,039
Total assets	115,076	161,531
Liabilities and Stockholders' Deficit
Accounts payable and accrued expenses	316,900	288,244
Accrued interest - related parties	1,050,746	1,050,671
Accrued expenses – related party	78,360	78,360
Notes payable – related parties	3,635,015	3,527,043
Total current liabilities	5,081,021	4,944,318
Total liabilities	5,081,021	4,944,318
Preferred stock, $0.01 par value: Authorized shares – 10,000,000 Issued and outstanding shares – 3,262 at March 31, 2014 and December 31, 2013	33	33
Common stock, $0.01par value: Authorized shares - 100,000,000 Issued and outstanding shares – 73,291,008 at March 31, 2014 and December 31, 2013	732,910	732,910
Additional paid-in capital	31,968,516	31,968,516
Accumulated deficit	(37,667,404)	(37,484,246)
Total stockholders' deficit	(4,965,945)	(4,782,787)
Total liabilities and stockholders’ deficit	$ 115,076	$ 161,531